Axinn partner James Hunsberger co-hosted ABA's Our Curious Amalgam podcast in an episode entitled, "More or (Even) Less Certainty in EU Merger Control?

Amidst volatility in the marketplace and international trade, how can economics help us understand prices and underlying concepts such as cost pass-through?

Competition law has evolved from a specialized legal domain into a critical enterprise risk that demands board-level attention. How can corporate directors effectively oversee antitrust compliance and protect their companies from regulatory exposure in an era of heightened enforcement?

Looking forward to presenting at the AIPLA IP Practice in Japan Mid-Winter Program in Houston, TX next week!

Every trial tells a story — but what happens when the storyteller becomes the judge? Managing Partner Jeny Maier joins Anora Wang as co-host for a wide-ranging conversation with the Honorable Judge Richard Franklin Boulware II about his extraordinary path from public defender to federal judge, and the lessons he's learned about persuasion, fairness, and the fine art of trial craft.

As we navigate the ever-evolving terrain of technology and market dynamics, it's vital to stay ahead with insights that transcend the moment. Partners Denise Plunkett and Bradley Justus...

Axinn partner Daniel Bitton and counsel Carol Liu co-authored the Tijdschrift Mededingingsrecht in de Praktijk article, "Biden's Antitrust Gamble."

Axinn Managing Partner Jeny Maier joins fashion and luxury industry counsel Andowah Newton and co-host Puja Patel on the American Bar Association's Our Curious Amalgam podcast to explore what happens when antitrust law meets high fashion.

On May 10, 2024, the USPTO posted a notice of proposed rulemaking (NPRM) soliciting comments regarding a proposed change concerning terminal disclaimers used to overcome non-statutory double patenting.

Managing Partner Jeny Maier and co-host Puja Patel welcome Baker McKenzie attorneys David Baay and Katia Boneva-Desmicht to the ABA Antitrust Section's podcast Our Curious Amalgam...

Managing Partner Jeny Maier appeared on the Capitol Forum's ABA Spring 2025 Interview Series to discuss the antitrust M&A enforcement landscape under the new Trump administration.

Federal enforcers continue to refine the tools they use in merger enforcement—including the use of prior approval provisions, once considered an extraordinary remedy in merger settlements.

Many practitioners wonder what it would be like to be an academic, diving deeply into the leading international legal and policy issues at the forefront of antitrust and competition law.

State attorneys general are taking a more active role in merger control, with Colorado and Washington leading the way on new "mini-HSR" pre-merger notification regimes.

The US antitrust agencies' approach to merger remedies has undergone a significant change under the Biden administration. Remedies are increasingly disfavored.

State attorneys general are playing an increasingly important role in antitrust enforcement.

Expanding the range of ways they can identify and investigate potential competition concerns in healthcare, DOJ, FTC, and HHS recently announced the introduction of HealthyCompetition.gov...

On April 15, 2024, in response to feedback on last year's ANPRM, Director Vidal issued an invitation to comment on the new NPRM governing PTAB review practices...

On Wednesday, March 11, 2026, United States Patent and Trademark Office (USPTO) Director John Squires issued a memorandum announcing that when making institution decisions in inter partes review (IPR) and post-grant review (PGR) proceedings, he would consider whether accused or licensed products and components were manufactured in the United States, as well as whether the petitioner was a small business that had been sued for infringement.

For those who have not had a chance to attend one of our CLE presentations on Litigation Funding Disclosure, this IAM article provides a glimpse of the complex landscape for defendants...